James M. Metz, M.D.

faculty photo
Henry K. Pancoast Professor of Radiation Oncology
Department: Radiation Oncology

Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
2 West
Philadelphia, PA 19104
Office: 215-349-5570
Fax: 215-349-5923
Education:
BS (Biology)
Juniata College , 1989.
MS (Clinical Immunology/Microbiology)
Hahnemann University , 1991.
MD (Medicine)
UMDNJ-Robert Wood Johnson Med School, 1995.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Dr. Metz serves as Chair of Radiation Oncology at the Perelman School of Medicine and holds the Henry K. Pancoast Endowed Professorship. He is Associate Director for Clinical Services and Programs at the Abramson Comprehensive Cancer Center of the University of Pennsylvania. Dr. Metz led the development of the Roberts Proton Therapy Center, the largest proton center in the world completely integrated with conventional cancer services. Dr. Metz has become an international leader in the application of proton therapy for the treatment of a variety of malignancies. He continues to work to integrate proton therapy as a new treatment paradigm for cancer and is leading the expansion of proton therapy.

Dr. Metz specializes in the use of radiation for the treatment of gastrointestinal malignancies. His research interests include the treatment of GI malignancies in the multidisciplinary setting, as well as the utilization of complementary and alternative medications by cancer patients, and use of the Internet to provide cancer related information. A major area of interest has been the development of proton therapy at Penn and internationally.

Dr. Metz also serves as Executive Director of OncoLink (www.oncolink.upenn.edu), the award winning Internet resource from the Abramson Comprehensive Cancer Center of the University of Pennsylvania that was founded in 1994. As Executive Director, Dr. Metz leads OncoLink’s mission to help cancer patients, families, health care professionals, and the general public find accurate cancer-related information online. The website has led the way in online education for cancer patients and healthcare providers, receiving numerous awards and recognition from most major authorities as one of the best cancer information websites. Currently OncoLink is developing interactive content and personalized information for individuals while collecting important information to move the field forward, particularly in the area of cancer survivorship. Its reach is international in scope with over 285,000 unique visitors served per month.

Selected Publications

Barsky AR, Kim MM, Maxwell R, Mendes A, Wright CM, Anstadt EJ, McNulty S, Dong L, Metz JM, Feigenberg SJ, Li T, Cengel KA.: Initial clinical experience treating patients with palliative radiotherapy for malignant pleural mesothelioma on the HalcyonTM linear accelerator. Ann Palliat Med. 2020 Aug 14:apm-20-385. doi: 10.21037/apm-20-385. Online ahead of print. August 2020.

Baumann BC, Hallahan DE, Michalski JM, Perez CA, Metz JM.: Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy. Baumann BC, Hallahan DE, Michalski JM, Perez CA, Metz JM.Br J Cancer. 2020 Jun 18. doi: 10.1038/s41416-020-0919-2. Online ahead of print. Br J Cancer. 2020 Jun 18. doi: 10.1038/s41416-020-0919-2. Online ahead of print. June 2020.

Coleman CN, Hoppe RT, Metz JM.: Eli J. Glatstein: A Steward Extraordinaire of Radiation Oncology. Int J Radiat Oncol Biol Phys.2020 May 1;107(1):1-5. doi: 10.1016/j.ijrobp.2020.01.016. Page: 1-5, May 2020.

Barsky AR, Reddy VK, Plastaras JP, Ben-Josef E, Metz JM, Wojcieszynski AP.: Proton beam re-irradiation for gastrointestinal malignancies: a systematic review. J Gastrointest Oncol. 2020 Feb;11(1):187-202. doi: 10.21037/jgo.2019.09.03. Page: 187-202, February 2020.

Benci JL, Vachani CC, Hampshire MK, Bach C, Arnold-Korzeniowski K, Metz JM, Hill-Kayser CE.: Factors Influencing Delivery of Cancer Survivorship Care Plans: A National Patterns of Care Study. Front Oncol. 2020 Jan 31;9:1577. doi: 10.3389/fonc.2019.01577. eCollection 2019. 2020.

Yoon SW, Lin H, Alonso-Basanta M, Anderson N, Apinorasethkul O, Cooper K, Dong L, Kempsey B, Marcel J, Metz J, Scheuermann R, Li T.: Initial Evaluation of a Novel Cone-Beam CT-Based Semi-Automated Online Adaptive Radiotherapy System for Head and Neck Cancer Treatment - A Timing and Automation Quality Study. Cureus. 2020 Aug 11;12(8):e9660. doi: 10.7759/cureus.9660. 2020.

Mante A, Hawrot K, Bvochora-Nsingo M, Chiyapo S, Balang D, Barg F, Baffic C, Monare B, Vapiwala N, Ralefala T, Metz J, Swisher-McClure S, Grover S.: Radiation Oncology Rotation in Botswana: Resident Experience and Career Interests. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):850-852. doi: 10.1016/j.ijrobp.2020.03.017. Epub 2020 May 5. Page: 850-852, 2020.

LaRiviere MJ, Santos PM, Hill-Kayser CE, Metz JM.: Proton Therapy. Hematology/Oncology Clinics 33(6): 989-1009, December 2019.

Baumann BC, Mitra N, Harton JG, Xiao Y, Wojcieszynski AP, Gabriel PE, Zhong H, Geng H, Doucette A, Wei J, O'Dwyer PJ, Bekelman JE, Metz JM.: Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer. JAMA Oncology 6(2): 237-246, December 2019.

Kim MM, Bollinger D, Kennedy C, Zou W, Scheuermann R, Teo BK, Metz JM, Dong L, Li T.: Dosimetric Characterization of the Dual Layer MLC System for an O-Ring Linear Accelerator. Technology in Cancer Research & Treatment 18, November 2019.

back to top
Last updated: 11/06/2020
The Trustees of the University of Pennsylvania